Compugen | CGEN - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Arca Biopharma USD -31.82M 2.24M 2026-03
aTyr Pharma USD -153K 25.59M 2026-03
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Cara Therapeutics USD -6.8M 1.9M 2026-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -7.66M 64.51M 2026-03
Immunic USD -19.3M 6.28M 2025-12
Minerva Neurosciences USD 22.51M 30.74M 2024-09
RedHill Biopharma USD -1.54M 12M 2024-06
TherapeuticsMD USD -1.05M 241K 2024-06